期刊文献+

慢性阻塞性肺疾病合并骨质疏松的危险因素分析 被引量:2

Analysis of Risk Factors of Chronic Obstructive Pulmonary Disease with Osteoporosis
下载PDF
导出
摘要 慢性阻塞性肺疾病(COPD)是世界范围内发病率高、病死率高、致残率高的一种持续气流受限性肺部疾病,骨质疏松是其主要并发症之一,极易导致椎体及髋部骨折,能够进一步加重整体疾病的严重程度。但针对骨质疏松导致的骨折等危害是可以避免的,需要掌握COPD合并骨质疏松的危险因素予适当干预,关于COPD合并骨质疏松的危险因素研究较多,但部分研究成果至今未得到广大学者的共识,则COPD合并骨质疏松危险因素的研究对于早期识别骨质疏松具有重要意义,为COPD患者预防、诊断、治疗骨质疏松这一并发症提供重要的理论依据和线索。 Chronic obstructive pulmonary disease(COPD) is a persistent airflow limitation puhnonary disease with high incidence,high mortality, and high morbidity worldwide. Osteoporosis, one of the major complications, can easily lead to vertebral and pelvic fractures, and further aggravate the severity of the disease as a whole. However, the harm of fracture caused by osteoporosis can be avoided by proper intervention to the risk factors. There are many studies on the risk factors of COPD with osteoporosis,but some of the research results have not been agreed by the majority of scholars up to now. The study of risk factors for COPD with osteoporosis has great significance for the early identification of osteoporosis and provides important theoretical basis and clues for the prevention,diagnosis and treatment of osteoporosis in COPD patients.
作者 郭婷婷 赵立 GUO Tingting;ZHAO Li(Department of Respiratory Medicine,Shengjing Hospital of China Medical University,Shenyang 110000,China)
出处 《医学综述》 2018年第20期4028-4032,共5页 Medical Recapitulate
关键词 慢性阻塞性肺疾病 骨质疏松 骨密度 危险因素 Chronic obstructive pulmonary disease Osteoporosis Bone mineral density Risk factors
  • 相关文献

参考文献3

二级参考文献9

  • 1Zhu YJ;Chen WB.Respiratory medicine(the first edition)[M]北京:人民卫生出版社,2003877-892. 被引量:1
  • 2Zhao YL,Fei JX,Liu QP,Shen LY. The effects of uptake of different does of casein combined with Chinese herbal drugs on diaphragm function in rats with emphysema[J].Journal of Hygiene Research,2011.162-163. 被引量:1
  • 3Society of Chronic Obstructive Pulmonary Disease,Branch Association of Respiratory Disease,Chinese Medical Association. Guide to diagnosis and treatment of chronic obstructive pulmonary disease (revision,2007)[J].Chinese J of Tuberculosis and Respiratory Diseases,2007.8-17. 被引量:1
  • 4Good Clinical Practice. Issued by State Food and Drug Administration[M].PRC in September 1,1999. 被引量:1
  • 5Celli BR,Cote CG,Matin JM,Casanova C Montes de Oca M Mendez RA Pinto Plata V Cabral HJ. The body-mass index,airflow obstruction,dyspnea,and exercise capacity index in chronic obstructive pulmonary disease[J].New England Journal of Medicine,2004.1005-1012. 被引量:1
  • 6Mahler DA,Wells CK. Evaluation of clinical methods for rating dyspnea[J].Chest,1988.580-586. 被引量:1
  • 7曾晖,杜靖远,郑启新.胰岛素样生长因子—1对骨形成的影响[J].中国矫形外科杂志,1998,5(5):457-458. 被引量:9
  • 8范宏斌,王全平.生长激素—胰岛素样生长因子轴与骨代谢[J].中国矫形外科杂志,1999,6(12):947-948. 被引量:2
  • 9Hanief Mohammad Shahjee,Nisan Bhattacharyya.Activation of Various Downstream Signaling Molecules by IGFBP-3[J].Journal of Cancer Therapy,2014,5(9):830-835. 被引量:3

共引文献309

同被引文献21

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部